Clinical characteristics and outcomes of thymoma‐associated myasthenia gravis
European Journal of Neurology2021Vol. 28(6), pp. 2083–2091
Citations Over TimeTop 10% of 2021 papers
Rodrigo Álvarez‐Velasco, Gerardo Gutiérrez‐Gutiérrez, Juan Carlos Trujillo, Elisabeth Martínez, Sonia Segovia, Marina Arribas‐Velasco, Guillermo Fernández, Carmen Paradas, Beatriz Gómez, Carlos Casasnovas, Velina Nedkova, A. Guerrero-Solá, Alba Ramos‐Fransí, Alicia Martínez‐Piñeiro, Julio Pardo, Teresa Sevilla, María Teresa Gómez‐Caravaca, Adolfo López de Munaín, Ivonne Jericó, Ana L. Pelayo‐Negro, María Asunción Martín, Yolanda Blanco Morgado, María Dolores Mendoza, Helena Pérez‐Pérez, Ricard Rojas‐García, Janina Turón‐Sans, Luís Querol, Eduard Gallardo, Isabel Illa, Elena Cortés‐Vicente
Abstract
Thymoma-associated MG patients had more severe myasthenic symptoms and worse prognosis. Thymoma recurrence was frequently associated with transient worsening of MG, but long-term prognosis did not differ from nonrecurrent thymoma. Patients with nonresectable thymoma tended to present severe forms of MG.
Related Papers
- → Thymoma, Myasthenia Gravis, and Other Paraneoplastic Syndromes(2008)109 cited
- → Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor(2008)29 cited
- → Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies(2011)12 cited
- → Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without Myasthenia gravis: relation to the onset of Myasthenia gravis(1991)13 cited
- [Clinical characteristics and outcome of myasthenia gravis with and without thymoma after operation].(2004)